Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2003
10/23/2003US20030198954 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198949 Viral polypeptides that regulate or modulate apoptosis
10/23/2003US20030198678 Polynucleotide immobilized with block polyether polymer; antibodies against genetic disorders
10/23/2003US20030198663 Phospholipid-analogous compounds
10/23/2003US20030198650 Equine herpes viruses; hybrid nucleic acid
10/23/2003US20030198647 Rheumatic diseases; autoimmune disease
10/23/2003US20030198640 Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta
10/23/2003US20030198627 siRNA knockout assay method and constructs
10/23/2003US20030198626 Induction gene expression in cells of major histocompatibility complex; antitumor agents
10/23/2003US20030198625 Electroporation-mediated transfection of the salivary gland
10/23/2003US20030198624 Cytokine gene expression therapy; antiinflammatory agnets, respiratory system disorders
10/23/2003US20030198623 Attenuation Dna; coding cytokines, tumor antigen
10/23/2003US20030198622 vaccine including a polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy
10/23/2003US20030198621 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
10/23/2003US20030198620 Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
10/23/2003US20030198618 T1 receptor-like ligand II and uses thereof
10/23/2003CA2482904A1 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003CA2482903A1 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003CA2482718A1 Derivatives of the il-2 receptor gamma chain, their production and use
10/23/2003CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
10/23/2003CA2482395A1 Antiviral therapy on the basis of rna interference
10/23/2003CA2482387A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003CA2481813A1 Antibody gene transfer and recombinant aav therefor
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481478A1 Stimulation of nerve cell regeneration
10/23/2003CA2481372A1 Method to inhibit cell growth using oligonucleotides
10/23/2003CA2481244A1 Recombining viral vectors for the tetracycline-regulated expression of genes
10/23/2003CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003CA2480775A1 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003CA2480079A1 Antiangiogenic active immunotherapy
10/23/2003CA2479996A1 Compositions for delivering enyzmes involved in acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolicdisorders using such raav virons
10/23/2003CA2479835A1 An ephrin-b receptor protein involved in carcinoma
10/22/2003EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen
10/22/2003EP1354961A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
10/22/2003EP1354949A1 Human fgf23 protein mutant lowering blood phosphorus level
10/22/2003EP1354945A1 Method of identifying within a mammala dna encoding physiologically active polypeptide
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354199A2 Diagnosis and treatment of multiple sclerosis
10/22/2003EP1354055A1 Neocentromere-based mini-chromosomes or artificial chromosomes
10/22/2003EP1354054A2 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/22/2003EP1354047A2 Methods for screening compounds that modulate lipid metabolism
10/22/2003EP1354046A2 A member of the lysyl oxidase gene family
10/22/2003EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1354039A2 Atp-binding cassette transporter-like molecules and uses thereof
10/22/2003EP1354032A2 Gene regulation therapy involving ferritin
10/22/2003EP1354029A2 Foggy
10/22/2003EP1353954A2 Anticoagulants and their uses
10/22/2003EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
10/22/2003EP1353942A2 Peptide inhibitors of hiv entry
10/22/2003EP1353941A2 Modified zinc finger binding proteins
10/22/2003EP1353702A2 Genetic engineering of vascular grafts to resist disease
10/22/2003EP1353688A2 Method and compositions for immunization with the pseudomonas v antigen
10/22/2003EP1353687A2 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof
10/22/2003EP1353661A2 Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
10/22/2003EP1353555A2 Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents
10/22/2003EP0986572B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
10/22/2003EP0851927B1 Compounds for immunotherapy and diagnosis of tuberculosis
10/22/2003EP0658209B1 Endothelial lineage specific transcriptional regulatory element from tek
10/22/2003CN1451046A 保守的奈瑟球菌抗原 Conservative Neisseria antigen
10/22/2003CN1451045A IFN-alpha homologues
10/22/2003CN1451042A Method of monitoring HIV drug resistance
10/22/2003CN1451016A Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method
10/22/2003CN1450912A CD40 antagonists for use in treating psoriasis and other inflammatory skin conditions
10/22/2003CN1450907A Beta glycan as an inhibin receptor and uses thereof
10/22/2003CN1449831A DNA vaccine pVPS2 for SARS virus
10/22/2003CN1449830A DNA vaccine pVFS for SARS virus
10/22/2003CN1449829A DNA vaccine pVPS for SARS virus
10/22/2003CN1449828A DNA vaccine pVPM for SARS virus
10/22/2003CN1449827A DNA vaccine pVPH for SARS virus
10/22/2003CN1449826A Gene vaccine for anti SARS coronal virus and use thereof
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/22/2003CA2424577A1 Use of huntingtin and related compounds for modulating cell survival
10/21/2003US6635744 Substantially pure fibroblast growth factor homologous factor-4 polypeptide having specified amino acid sequence; diagnosis and treatment of neurodegenerative and neoplastic disorders
10/21/2003US6635743 Isolated antibody or portion that binds to protein selected from those having specified amino acid sequences or fragments; control apoptosis for treatment of autoimmune disease, graft versus host disease, rheumatoid arthritis and lymphadenopathy
10/21/2003US6635739 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
10/21/2003US6635624 Plasmid of partly bacterial origin; antibiotic resistance
10/21/2003US6635623 Early detection of cancer, metastatic cancer and/or arteriosclerosis
10/21/2003US6635614 Use of lecithin-cholesterol acyltransferase (LCAT) to reduce accumulation of cholesterol
10/21/2003US6635480 Of given amino acid sequence; use in detecting and treating cell proliferation and immunological disorders by modulating its activity
10/21/2003US6635479 Hypothalamus-specific polypeptides
10/21/2003US6635476 Complex of recombinant virus-chelating peptide covalently linked to ligand through a transition metal ion; kinetically stable; use in delivering a therapeutic or diagnostic agent to a cell
10/21/2003US6635473 Isolated nucleic acid encoding a fibrinogen-binding protein; useful in prevention, diagnosis and treatment of infections; can be administered to wounds or for coating prosthetics to inhibit binding of the bacteria
10/21/2003US6635472 Polynucleotide constructs which can replicate episomally in vertebrate cells without integration into the chromosomal DNA of the host; reverse transcription; use in gene transfer, gene therapy and vaccines
10/21/2003US6635466 Adenovirus serotype 30 (Ad30)
10/21/2003US6635461 Encoded by isolated nucleic acid; has glycosyltransferase activity; given amino acid sequence; useful as diagnostic and therapeutic agent for cancer and thymus-related disorders
10/21/2003US6635431 Recombinant lipolysis stimulated (LSR) comprising polypeptide of given sequence; use for selecting a compound for enhancing lipoprotein uptake in cells expressing the polypeptide
10/21/2003US6635421 Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
10/21/2003US6635258 Herpes simplex virus VP22 vaccines and methods of use
10/21/2003US6635252 Antibodies to superoxide dismutase-4
10/21/2003US6635249 Methods for treating congestive heart failure
10/21/2003US6635244 Adenovirus E1B-55K single amino acid mutants and methods of use
10/16/2003WO2003085377A2 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003WO2003085125A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/16/2003WO2003085117A1 Viral vectors comprising a nucleic sequence derived from murine leukemia viruses for gene transfer in cells
10/16/2003WO2003085110A2 Oligomeric compounds for the modulation hif-1alpha expression
10/16/2003WO2003085106A1 Preventives and/or remedies for cancer
10/16/2003WO2003085090A2 A human ribonucleotide reductase m2 subunit
10/16/2003WO2003085085A2 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
1 ... 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 ... 870